| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |